IQVIA Hldgs Analyst Ratings
Barclays Lowers Price Target on IQVIA Holdings to $255 From $275
IQVIA Hldgs Analyst Ratings
Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target
IQVIA Holdings (IQV) Gets a Buy From Jefferies
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV)
Stifel Adjusts Price Target on IQVIA Holdings to $288 From $294
UBS Adjusts Price Target on IQVIA Holdings to $295 From $300, Maintains Buy Rating
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $292
Buy Rating Affirmed for IQVIA Holdings Amidst Strong Growth and Resilient Demand
IQVIA Holdings (IQV) Receives a Buy From Truist Financial
Evercore ISI Adjusts Price Target on IQVIA to $250 From $275
IQVIA Hldgs Analyst Ratings
Baird: Maintaining the IQVIA Hldgs (IQV.US) rating, adjusted from neutral to neutral, and adjusted the target price from $254.00 to $245.00.
Bank of America Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
IQVIA Holdings (IQV) Gets a Buy From Barclays
Truist Financial Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), United Therapeutics (UTHR) and Immunome (IMNM)
Truist Financial Sticks to Their Buy Rating for IQVIA Holdings (IQV)